Trends in hepatitis A in Catalonia;Evolución de la hepatitis A en Cataluña

Vacunas

Volumn 8, Issue 1, 2007, Pages 9-13

  Batalla, J ^a   Urbiztondo, L ^a   Martinez M ^a   Borras, E ^a   Dominguez A ^a  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Effectiveness of the hepatitis A vaccine; Hepatitis A; Vaccination programme; Vaccination strategies

Indexed keywords

HEPATITIS A VACCINE;

ADULT; ARTICLE; ENDEMIC DISEASE; HEALTH PROGRAM; HEPATITIS A; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; SPAIN; VACCINATION;

EID: 37849026817     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(07)73965-1     Document Type: Article

References (16)

1. Coursaget P, Leboulleux D, Gharbi Y, et al. Etiology of acurate sporadic hepatitis in adults in Senegal and Tunisian. Scand J Infect Dis. 1995;27:9-11.
2. Tsega E, Mengesha B, Hansson BG, et al. Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data. Am J Epidemiol. 1986;123:344-51.
3. Green MS, Block C, Slater PE. Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. Rev Infect Dis. 1989;11:464-9.
4. Departament de Sanitat i Seguretat Social. Manual de vacunacions. Quaderns de Salud Pública, 14. 3.a ed. Barcelona: Generalitat de Catalunya; 2000. p. 52-3.
5. Li JW, Xin ZT, Wang XW, Zheng JL, Chao FH. Mechanisms of inactivation of hepatitis A virus by chlorine. Appl Environ Microbiol. 2002;68:4951-5.
6. Grabow WO, Gauss-Muller V, Prozesky OW, Deinhardt F. Inactivation of hepatitis A virus and indicator organisms in water by free chlorine residuals. Appl Environ Microbiol. 1983;46:619-24.
7. Hambidge A. Reviewing efficacy of alternative water treatment techniques. Health Estate. 2001;55:23-5.
8. Domínguez A, Salleras L, Carmina G, Batalla J. Effectiveness of program of mass hepatitis A in preadoleascents. Vaccine. 2003;21:698-701.
9. Feinstone SM, Gust ID. Hepatitis A virus. En: Richman DD, Whitley RJ, Hayden FG, editors. Clinical Virology. 2nd ed. Washington: American Society for Microbiology; 2002. p. 1019-37.
10. Halliday ML, Kang LY, Zhou TK, et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shangai, China. J Infect Dis. 1991;164:852-9.
11. Franco E, Vitiello G. Vaccination strategies against hepatitis A in Southern Europe. Vaccine. 2003;21:696-7.
12. Departament de Salut. Resum de les malalties de declaració obligatòria a Catalunya durant l'any 2003. Butlletí Epidemiològic de Catalunya. 2004;XXV:177-85.
13. Salleras L, Bruguera M, Vidal J, et al. Cambio en el patrón seroepidemiológico de la hepatitis A en España. Med Clin (Barc). 1992;99:87-9.
14. Bruguera M, Salleras L, Plans P, et al. Cambios en la seroepidemiología de la hepatitis A en Cataluña en el período 1989-1996. Implicaciones para una nueva estrategia vacunal. Med Clin (Barc). 1999;112:406-8.
15. Salleras L, Bruguera M, Buti M, et al. Prospects for vaccination against hepatitis A and B in Catalonia (Spain). Vaccine. 2000;18:S80-2.
16. Domínguez A, Torner N, Carmona G. En: Campins M, Moraga FA, editores. Vacunas 2005. Barcelona: Prous Science; 2005. p. 27.